The effects of blood transfusion on cytokine production by TH1 and TH2 lymphocytes in the mouse

Transplantation

Volumn 61, Issue 3, 1996, Pages 465-468

  Babcock, George F ^a   Alexander, J Wesley ^a  

^a UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN PRESENTATION; ANTIGEN RECOGNITION; ARTICLE; ATTENUATION; BLOOD TRANSFUSION; CONTROLLED STUDY; GRAFT SURVIVAL; IMMUNE RESPONSE; IMMUNOSUPPRESSIVE TREATMENT; MALE; MIXED LYMPHOCYTE REACTION; MOUSE; NONHUMAN; ORGAN TRANSPLANTATION; PRIORITY JOURNAL;

ANIMALS; ANTIGEN PRESENTATION; BLOOD TRANSFUSION; CYTOKINES; FEMALE; IMMUNE TOLERANCE; IMMUNITY, CELLULAR; MACROPHAGES; MALE; MICE; MICE, INBRED AKR; MICE, INBRED BALB C; SPLEEN; TH1 CELLS; TH2 CELLS; TRANSPLANTATION, HOMOLOGOUS;

EID: 0030041449     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199602150-00026     Document Type: Article

References (23)

1. Quigley RL, Wood KF, Morris PJ. Transfusion induces blood donor- specific suppressor cells. J Immunol 1989; 142: 463.
2. Quigley RL, Wood DJ, Morris PJ. Investigation of the mechanism of active enhancement of renal allograft survival by blood transfusion. Immunology 1988; 63: 373.
3. Bushnell A, Pearson TC, Morris PF, Wood KJ. Donor-specific unresponsiveness to cardiac allografts in the mouse: an examination of mechanisms. Transplant Proc 1991; 23: 726.
4. Opelz G, Senger DPS, Mickey MR, Terasaki PI. Effect of blood transfusions on subsequent kidney transplants. Transplant Proc 1973; 5: 253.
5. Salvatierra O, Bicenti F, Amend W, et al. Deliberate donor specific blood transfusions prior to living related renal transplantation: a new approach. Ann Surg 1980; 192; 543.
6. Alexander JW, Babcock, GF, First MR, et al. The induction of immunologic hyporesponsiveness by preoperative donor specific transfusion and cyclosporine in human cadaveric transplants. Transplantation 1992; 52: 423.
7. Davies DB, Alexander JW, Cofer BR, et al. Efficacy of a single pretransplant donor specific transfusion and cyclosporine A administered 24-48 hours prior to one-haplotype mismatched living related donor kidney transplants. Ann Surg 1992; 215: 618.
8. Alexander JW, First RM, Davis CB, Campbell P, Babcock GF. Donor-specific transfusion-induced tolerance in animals and man: a therapeutic strategy. Transplant Sci 1993; 3: 72.
9. Tchervenkov JI, Epstein MD, Alexander JW, Schroeder TJ. The effect of donor-specific blood transfusion, cyclosporine, and dietary prostaglandin precursors on rat cardiac allograft survival: II. Effectiveness of a 24-hour induction period with DST and CsA is effective in inducing long-term graft survival Transplantation 1989; 47: 177.
10. Brunson ME, Tchervenkov JI, Alexander JW. Enchancement of allograft survival by DST one day prior to transplant-importance of timing and specificity when DST is given with cyclosporine. Transplantation 1991; 52: 545.
11. Davies CB, Cofer BR, Alexander JW. Effects of donor specific transfusion, cyclosporine A and FD506 on rat cardiac allograft survival. Transplant Proc 1991; 23: 3314.
12. Babcock GF, Smith L, Alexander JW. A comparison of single and multiple blood transfusions in the mixed lymphocyte response of rats. Transplant Proc 1988; 20: 1213.
13. Takeuchi T, Lowry RP, Konieczny B. Heart allografts in murine systems: the differential activation of Th2-like effector cells in peripheral tolerance. Transplantation 1992; 53: 1281.
14. Dallman MJ, Shiho O, Page TH, et al. Pheripheral tolerance to alloantigen results from altered regulation of the interleukin 2 pathway. J Exp Med 1991; 173: 79.
15. Paliogianni F, Kincaid R, Boumpas D. Prostaglandin E2 and other cyclic AMP elevating agents inhibit interleukin 2 gene transcription by counteracting calcineurin-dependent pathways. J Exp Med 1993; 178: 1813.
16. Taga K, Tosato G. IL-10 inhibits human T cell proliferation and IL-2 production. J Immunol 1992; 148: 1143.
17. Betz M, Fox BS. Prostaglandin E2 inhibits production of Th1 lymphokines but not Th2 lymphokines. J Immunol 1991; 146: 108.
18. Stephan RN, Kisala JM, Dean RE, et al. Effect of blood transfusion on antigen presentation function and on interleukin 2 generation. Arch Surg 1988; 123: 235.
19. Shelby J, Marushack M, Nelson E. Prostaglandin production and suppressor cell induction in transfusion induced immune suppression. Transplantation 1985; 43: 113.
20. Fitch FW, McKisic MD, Lancki DW, Gajewski TF. Differential regulation of murine T lymphocyte subsets. Annu Rev Immunol 1993; 11: 29.
21. Moore KW, O'Garra A, de Waal Malefyt R, Vieira P, Mosmann TR. Interleukin-10. Annu Rev Immunol 1993; 11: 165.
22. de Waal Malefyt R, Haanen J, Sptits H, et al. IL-10 and viral IL-10 strongly reduce antigen-specfifc human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via down regulation of class II MHC expression. J Exp Med 1991; 174: 915.
23. Fiorentio DD, Zlotnik A, Vieia P, et al. IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells. J Immunol 1991; 146: 3444.